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| INTRODUCTION
Hepatitis C virus (HCV) is a global concern, affecting roughly 184 million people worldwide, and it is the most common blood-borne infection in the United States. [1] [2] [3] [4] Left untreated, HCV often leads to chronic liver disease including cirrhosis, liver cancer, and extrahepatic complications. [5] [6] [7] Until recently, multidrug HCV treatment regimens lasted 24 to 48 weeks, had low cure rates, and were often accompanied by moderate to severe side effects, which made adherence and completion of treatment a challenge for many patients. [8] [9] [10] [11] Some of the side effects could be alleviated by adjusting the dosage of medication, but this required specialist knowledge of HCV and the medications.
The treatment of HCV was transformed with the introduction of highly effective direct-acting antivirals in 2013. 12, 13 Current HCV treatments include several 8-or 12-week once-daily single-pill oral regimen options with limited side effects. These treatments do not require frequent clinical monitoring and are highly effective in curing HCV infection. The ease of administration and few side effects facilitate adherence and increase the likelihood of treatment completion and achieving a cure (sustained viral response); reported rates of sustained viral response in clinical trials and some observational cohorts exceed 90%. [14] [15] [16] [17] With the availability of these new medications, the demand for HCV treatment has grown. However, the number of clinicians experienced in and willing to treat HCV infection is insufficient to meet the demand, and more providers are needed to meet the needs of HCV patients seeking care and treatment. 9, 18, 19 Further limiting access to care is a requirement by a majority of state Medicaid programs in the United States that require an HCV specialist either prescribe or consult on the prescription of HCV medications. 20 The term telemedicine is widely used to describe the remote provision of health care using some form of video telecommunication and is typically used for remote monitoring of patients. [25] [26] [27] Telemedicine is typically used to diagnose and monitor patients in rural settings and in prisons and typically refers to an encounter between provider and patient. [28] [29] [30] In contrast, "telementoring" refers to a provider-to-provider relationship and has more often been applied to surgical specialists who provide assistance to surgeons in remote locations including battlefields and underserved, rural areas. [31] [32] [33] [34] Telementoring is essentially real-time technical assistance and guidance between a provider with specialized information and a remote provider who is the recipient of the information. 35 Reported benefits of surgical telementoring include the ability to share the latest surgical techniques with remote providers which in turn allows patients to benefit from the receipt of more advanced care locally. 32, 33 3 | RESULTS
| Survey results
Of the 18 providers participating in the project, 72% (n = 13) completed all 3 of the telementoring surveys: one survey at baseline with follow-up surveys at the 6-and 12-month intervals. Of the 5 who did not complete all of the surveys, 4 were HCV specialists and one was a PCP who left to work elsewhere in the first year of the project. A description and count of providers from each site who were included in our quantitative and qualitative analyses are given in Table 1 . There were no substantial differences between sites in either the quantitative or the qualitative result.
Providers were asked to rate their perceived ability to perform certain HCV care-related tasks at baseline and again at 12 months.
Of all the changes related to the program, the greatest improvement was in perceived "ability to serve as a consultant within my clinic for HCV questions and concerns," with an average score of 6.08 (scored 1-7) at 12 months, compared with 4.56 at baseline (P < .05). The second greatest increases were seen in perceived ability to educate and motivate patients with HCV infection and ability to educate clinic staff about patients with HCV, with the former going from 5.29 at baseline to 6.31 at 12 months (P < .05) and the latter going from an average of 5.22 to 6.23 (P < .05 for both). A statistically significant change was also observed in providers' perceived ability to identify suitable candidates for HCV treatment, going from 5.28 to 6.31 ( Table 2 ). The ability of providers to assess and manage substance use disorder problems among their HCV patients and to manage psychiatric comorbidities in their HCV patients did not significantly change from baseline to 12-month follow-up.
Providers were also queried on their satisfaction with participating in Project INSPIRE after 6 months. All providers (100%) said they would recommend the program to a colleague even though one-third (33%) felt that the project increased their workload. A majority (83%) of the providers felt that the project had decreased the number of traditional consultations while 6% disagreed and 11% did not know. All of the providers (100%) agreed that the project improved the quality of patient care and 94% reported greater job satisfaction (Table 3 ).
There were no statistically significant differences in the responses when the questions were repeated after 12 months compared with the 6-month responses.
| Qualitative interview results
Fourteen of the 18 (78%) participating providers agreed to be interviewed, 7 from each of the 2 medical centers. All of the HCV specialists who were interviewed were from one institution; providers from the other institution were primarily PCPs, including 2 infectious diseases specialists who provided HIV primary care. During the semistructured interviews, providers were specifically asked to describe their satisfaction with the telementoring sessions. One question also asked them to describe the greatest benefit of participating in Project INSPIRE. Three dominant themes emerged from their responses, 2 of which were directly related to the benefits of the telementoring (the third described the benefit of having a care coordinator available to work with patients): who regularly attended the telementoring sessions and who were not HCV specialists described the value of being able to present some of their cases during the telementoring sessions and then receiving real-time feedback from others. This was described as particularly helpful in learning how to treat HIV/HCV-coinfected and more complex patients. One provider who has many coinfected patients described the benefit of receiving feedback on these patients during the telementoring sessions in this way:
To have that sort of real-time feedback, the chance for more of an interaction, a conversation about it, is very helpful.
Half of the HCV specialists attended the webinar series regularly, but even those who attended less frequently reported satisfaction with the program in general and said that whether they were presenting or simply attending, it was a good opportunity to reinforce their knowledge.
Of the 6 providers who reported their professional growth as the biggest benefit, 3 also stated that they felt like they were part of a larger team and that the collegiality that developed had a positive impact on their job satisfaction and professional growth, including increased confidence in their ability. One provider who became the "go-to" person for HCV-related information at her clinic described how the telementoring service had allowed her to grow as a clinician and to become a source of information for patients and other clinicians at her clinic. Another clinician described how the telementoring service brought the HCV providers together and how that created a sense of comradery among the participating providers.
The team-building-the experience of being part of a larger team; I think that's very empowering and makes me more comfortable working with more challenging patients.
The next most commonly stated benefit of taking part in Project INSPIRE by PCPs was the ability to treat their own patients rather than referring them to a specialist for care. These providers said this also benefitted their patients who might be reluctant to see a specialist because of perceived stigma. One provider described how this change in her practice affected her personally.
The amount I've learned about treating folks with Hep C and how gratifying it is … just being able to see people .033
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Abbreviation: HCV, hepatitis C virus.
Response key: 1 = no skill; 2 = vague knowledge; 3 = slight knowledge; 4 = average among peers; 5 = competent; 6 = very competent; 7 = expert. *Paired t tests were used to test for statistically significant changes among providers who completed both baseline and follow-up surveys.
who have been sick for a long time get better-it's really gratifying in a number of ways. Emotionally and intellectually, it's been a wonderful experience.
Another reason providers felt that the project had positively impacted their patients was the convenience of being treated in the same clinic where they went to for primary care and not having to get to a different clinic to see another provider. One provider described how some patients are reluctant to keep appointments with other providers and her ability to treat them at their regular clinic has allowed them to get treated.
I try not to refer people out of the clinic, and part of that is because the more referrals you have to do out of the clinic, the less likely something's going to actually happen, because then people have to make their way to another appointment and they have to see another provider and establish care with another provider. If you're able to keep it where they feel comfortable and supported … then they're more likely to make it through treatment.
Some of the providers of HCV/HIV-coinfected patients also discussed the satisfaction of being able to tell patients that they were now cured of disease. One PCP described how he will never be able to cure someone of their diabetes, but he can cure their HCV and relieve them of that burden. providers also reported increased self-confidence as a result of the knowledge attained and the ability to begin treating their own patients rather than having to refer them out. Abbreviations: HCV, hepatitis C virus; PCP, primary care provider.
For 6-month data, n = 18 (10 PCPs; 4 HCV specialists; 4 HIV specialists); 12-month data, n = 13 (9 PCPs; 4 HIV specialists).
The ability to treat their own patients was important to the PCPs because it enhanced the continuity of care for their patients by removing a potential barrier of having patients see a different provider at another location. For providers with HCV/HIV-coinfected patients, the PCPs also described the satisfaction of being able to cure a patient of one disease and how gratifying that was for both them and the patients. Clinicians also valued the opportunity that telementoring pro- Bruce R. Schackman http://orcid.org/0000-0002-1132-2932
